$FLGT

Fulgent Genetics (FLGT) CFO has 2,747 shares withheld for RSU taxes

Fulgent Genetics' CFO and Treasurer, Paul Kim, had 2,747 shares of common stock withheld on April 26, 2026, to cover tax obligations arising from the vesting of restricted stock units. This was a routine tax-related disposition, not an open-market sale, and the shares were valued at $16.31 each. Following this transaction, Kim continues to hold a substantial 365,800 shares of Fulgent common stock.

Original reporting
Published Apr 28, 2026, 8:51 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 28, 2026, 9:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$FLGT
Neutral
medium confidence
Mentioned
$FLGT
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$FLGTNeutralLow
01

Why it matters

This transaction is routine and does not reflect new information about the company's financial health or prospects.

02

Market read

The event has minimal impact on the company's stock and is unlikely to influence market perception.

03

What to watch

This activity is routine and does not indicate insider trading or material information; overinterpreting could lead to unnecessary trading.

Timing: low

Background

The CFO of Fulgent Genetics withheld shares to cover tax obligations from vested RSUs, a common practice among executives.

Company-level read

Ticker impact

$FLGTNeutralMedium confidence
Context

The insider transaction involves the CFO of Fulgent Genetics, indicating potential insider confidence or tax planning activities.

Expected impact

Minimal to no impact on stock price; likely negligible movement.

Evidence & confidence

Such tax-related withholding is common and does not reflect a change in company fundamentals or insider sentiment.

Market effects

Limited; this insider activity is specific to company tax obligations and does not indicate sector-wide changes.

None; event is company-specific and internal.

Negligible; no broader market implications.

Counterpoint

Some traders might interpret insider withholding as a sign of confidence in future stock performance, potentially leading to a slight positive bias.

Key entities

  • Fulgent Genetics

    A biotechnology company specializing in genetic testing.

  • Paul Kim

    CFO and Treasurer of Fulgent Genetics.

Related articles

$FLGTMedAI 8/10

Fulgent Genetics (FLGT) Q2 2026 Earnings Call Transcript

Fulgent Genetics (FLGT) reported Q2 2026 revenue of $85.4M, up 4% year over year and 20% sequentially, driven by Bako Diagnostics and StrataDX integration. Non-GAAP gross margin was 31.3% and Adjusted EBITDA was a $17.1M loss. Full-year revenue guidance was cut to $330M-$340M due to lower collection rates from a billing system transition.

$FLGTMed

Fulgent Genetics, Inc. (FLGT): Results of Operations and Financial Condition

Fulgent Genetics, Inc. (FLGT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 flgt-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Fulgent Reports Second Quarter 2026 Financial Results • Revenue of $85.4 million, growing 20.1% sequentially • GAAP gross profit of $25.7 million, or GAAP gross margin of 30.1%; Non-GAAP gross profit of $26.8 million, or Non-

$NVDAMed

Nvidia to Invest Up to $3 Billion in Blackstone

The Information reported Nvidia plans to invest up to $3 billion in Lancium, a Blackstone-backed power and data center infrastructure developer tied to the Stargate AI initiative. Nvidia would initially put in $2 billion for a 20% stake, with up to $1 billion more contingent on performance thresholds. No company comment was provided.

$NVDAMed

Nvidia to invest up to US$3 billion in Stargate data centre developer Lancium: The Information

Nvidia plans to invest up to $3 billion in Lancium, the developer of the Stargate data center campus in Texas, The Information reported. Nvidia would invest $2 billion for about a 20% stake, with an additional $1 billion possible based on grid hookup thresholds. Lancium’s land and power portfolio has an enterprise value near $10 billion, and it may explore an IPO in 2027.

SK Hynix mulling options for US$3 bil Chongqing plant — Bloomberg

Bloomberg reports SK Hynix is exploring options for its Chongqing, China semiconductor packaging and testing plant, including possibly bringing in an investor. A potential stake sale could value the facility at about US$3 billion, according to people familiar. Separately, SK Hynix plans a 54 trillion won (US$38 billion) South Korea expansion for DRAM and NAND, citing AI-driven demand.